Vaccination with IL-7 gene-modified autologous melanoma cells can enhance the anti-melanoma lytic activity in peripheral blood of patients with a good clinical performance status: a clinical phase I study (Q36292705)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Vaccination with IL-7 gene-modified autologous melanoma cells can enhance the anti-melanoma lytic activity in peripheral blood of patients with a good clinical performance status: a clinical phase I study |
scientific article |
Statements
1 reference
Vaccination with IL-7 gene-modified autologous melanoma cells can enhance the anti-melanoma lytic activity in peripheral blood of patients with a good clinical performance status: a clinical phase I study (English)
1 reference
Möller P
1 reference
Sun Y
1 reference
Dorbic T
1 reference
Alijagic S
1 reference
Makki A
1 reference
Jurgovsky K
1 reference
Schroff M
1 reference
Henz BM
1 reference
Wittig B
1 reference
Schadendorf D
1 reference
1 June 1998
1 reference
1 reference
1907-1916
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference